The Genetic Puzzle of Familial Atrial Fibrillation

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2020 Mar 3

PMID 32118049

Citations 17

Authors

Ahmed A Y Ragab

Gustaf D S Sitorus

Bianca B J J M Brundel

Natasja M S de Groot

Affiliations

Soon will be listed here.

Abstract

Atrial fibrillation (AF) is the most common clinical tachyarrhythmia. In Europe, AF is expected to reach a prevalence of 18 million by 2060. This estimate will increase hospitalization for AF to 4 million and 120 million outpatient visits. Besides being an independent risk factor for mortality, AF is also associated with an increased risk of morbidities. Although there are many well-defined risk factors for developing AF, no identifiable risk factors or cardiac pathology is seen in up to 30% of the cases. The heritability of AF has been investigated in depth since the first report of familial atrial fibrillation (FAF) in 1936. Despite the limited value of animal models, the advances in molecular genetics enabled identification of many common and rare variants related to FAF. The importance of AF heritability originates from the high prevalence of lone AF and the lack of clear understanding of the underlying pathophysiology. A better understanding of FAF will facilitate early identification of people at high risk of developing FAF and subsequent development of more effective management options. In this review, we reviewed FAF epidemiological studies, identified common and rare variants, and discussed their clinical implications and contributions to developing new personalized therapeutic strategies.

Citing Articles

Genetic and Molecular Underpinnings of Atrial Fibrillation.

Sweat M, Pu W NPJ Cardiovasc Health. 2025; 1.

PMID: 39867228 PMC: 11759492. DOI: 10.1038/s44325-024-00035-5.

The Current State of Realistic Heart Models for Disease Modelling and Cardiotoxicity.

Kistamas K, Lamberto F, Vaiciuleviciute R, Leal F, Muenthaisong S, Marte L Int J Mol Sci. 2024; 25(17).

PMID: 39273136 PMC: 11394806. DOI: 10.3390/ijms25179186.

Genetics, transcriptomics, metagenomics, and metabolomics in the pathogenesis and prediction of atrial fibrillation.

Linna-Kuosmanen S, Vuori M, Kiviniemi T, Palmu J, Niiranen T Eur Heart J Suppl. 2024; 26(Suppl 4):iv33-iv40.

PMID: 39099578 PMC: 11292413. DOI: 10.1093/eurheartjsupp/suae072.

Identification of common mechanisms and biomarkers of atrial fibrillation and heart failure based on machine learning.

Zhang Z, Ding J, Mi X, Lin Y, Li X, Lian J ESC Heart Fail. 2024; 11(4):2323-2333.

PMID: 38656659 PMC: 11287325. DOI: 10.1002/ehf2.14799.

Pathophysiology of Atrial Fibrillation and Approach to Therapy in Subjects Less than 60 Years Old.

Curcio A, Scalise R, Indolfi C Int J Mol Sci. 2024; 25(2).

PMID: 38255832 PMC: 10815447. DOI: 10.3390/ijms25020758.

References

Parvez B, Vaglio J, Rowan S, Muhammad R, Kucera G, Stubblefield T . Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation. J Am Coll Cardiol. 2012; 60(6):539-45. PMC: 3411889. DOI: 10.1016/j.jacc.2012.01.070. View

Ravn L, Aizawa Y, Pollevick G, Hofman-Bang J, Cordeiro J, Dixen U . Gain of function in IKs secondary to a mutation in KCNE5 associated with atrial fibrillation. Heart Rhythm. 2008; 5(3):427-35. PMC: 2515863. DOI: 10.1016/j.hrthm.2007.12.019. View

Zhang X, Chen S, Yoo S, Chakrabarti S, Zhang T, Ke T . Mutation in nuclear pore component NUP155 leads to atrial fibrillation and early sudden cardiac death. Cell. 2008; 135(6):1017-27. DOI: 10.1016/j.cell.2008.10.022. View

Dautova Y, Zhang Y, Sabir I, Grace A, Huang C . Atrial arrhythmogenesis in wild-type and Scn5a+/delta murine hearts modelling LQT3 syndrome. Pflugers Arch. 2009; 458(3):443-57. PMC: 2691533. DOI: 10.1007/s00424-008-0633-z. View

Volonte D, McTiernan C, Drab M, Kasper M, Galbiati F . Caveolin-1 and caveolin-3 form heterooligomeric complexes in atrial cardiac myocytes that are required for doxorubicin-induced apoptosis. Am J Physiol Heart Circ Physiol. 2007; 294(1):H392-401. DOI: 10.1152/ajpheart.01039.2007. View

Christophersen I, Steen Ravn L, Budtz-Joergensen E, Skytthe A, Haunsoe S, Svendsen J . Familial aggregation of atrial fibrillation: a study in Danish twins. Circ Arrhythm Electrophysiol. 2009; 2(4):378-83. PMC: 2760022. DOI: 10.1161/CIRCEP.108.786665. View

Yang M, Camara A, Aldakkak M, Kwok W, Stowe D . Identity and function of a cardiac mitochondrial small conductance Ca-activated K channel splice variant. Biochim Biophys Acta Bioenerg. 2017; 1858(6):442-458. PMC: 5749404. DOI: 10.1016/j.bbabio.2017.03.005. View

He W, Dai C, Li Y, Zeng G, Monga S, Liu Y . Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol. 2009; 20(4):765-76. PMC: 2663839. DOI: 10.1681/ASN.2008060566. View

Johnson J, Tester D, Perry J, Salisbury B, Reed C, Ackerman M . Prevalence of early-onset atrial fibrillation in congenital long QT syndrome. Heart Rhythm. 2008; 5(5):704-9. PMC: 3940082. DOI: 10.1016/j.hrthm.2008.02.007. View

10.

Li R, Wang Q, Xu Y, Zhang M, Qu X, Liu X . Mutations of the SCN4B-encoded sodium channel β4 subunit in familial atrial fibrillation. Int J Mol Med. 2013; 32(1):144-50. DOI: 10.3892/ijmm.2013.1355. View

11.

Tsai C, Hsieh C, Chang S, Chuang E, Juang J, Lin L . Next-generation sequencing of nine atrial fibrillation candidate genes identified novel de novo mutations in patients with extreme trait of atrial fibrillation. J Med Genet. 2014; 52(1):28-36. DOI: 10.1136/jmedgenet-2014-102618. View

12.

Yuan F, Qiu X, Li R, Qu X, Wang J, Xu Y . A novel NKX2-5 loss-of-function mutation predisposes to familial dilated cardiomyopathy and arrhythmias. Int J Mol Med. 2014; 35(2):478-86. DOI: 10.3892/ijmm.2014.2029. View

13.

S Olesen M, Bentzen B, Nielsen J, Steffensen A, David J, Jabbari J . Mutations in the potassium channel subunit KCNE1 are associated with early-onset familial atrial fibrillation. BMC Med Genet. 2012; 13:24. PMC: 3359244. DOI: 10.1186/1471-2350-13-24. View

14.

Macri V, Mahida S, Zhang M, Sinner M, Dolmatova E, Tucker N . A novel trafficking-defective HCN4 mutation is associated with early-onset atrial fibrillation. Heart Rhythm. 2014; 11(6):1055-1062. PMC: 4130372. DOI: 10.1016/j.hrthm.2014.03.002. View

15.

Andrade J, Khairy P, Dobrev D, Nattel S . The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014; 114(9):1453-68. DOI: 10.1161/CIRCRESAHA.114.303211. View

16.

Parvez B, Shoemaker M, Muhammad R, Richardson R, Jiang L, Blair M . Common genetic polymorphism at 4q25 locus predicts atrial fibrillation recurrence after successful cardioversion. Heart Rhythm. 2013; 10(6):849-55. PMC: 3690553. DOI: 10.1016/j.hrthm.2013.02.018. View

17.

Chen Y, Xu S, Bendahhou S, Wang X, Wang Y, Xu W . KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science. 2003; 299(5604):251-4. DOI: 10.1126/science.1077771. View

18.

Chen Z, Huang W, Dahme T, Rottbauer W, Ackerman M, Xu X . Depletion of zebrafish essential and regulatory myosin light chains reduces cardiac function through distinct mechanisms. Cardiovasc Res. 2008; 79(1):97-108. PMC: 2724891. DOI: 10.1093/cvr/cvn073. View

19.

Oberti C, Wang L, Li L, Dong J, Rao S, Du W . Genome-wide linkage scan identifies a novel genetic locus on chromosome 5p13 for neonatal atrial fibrillation associated with sudden death and variable cardiomyopathy. Circulation. 2004; 110(25):3753-9. PMC: 1618875. DOI: 10.1161/01.CIR.0000150333.87176.C7. View

20.

Head C, Balasubramaniam R, Thomas G, Goddard C, Lei M, Colledge W . Paced electrogram fractionation analysis of arrhythmogenic tendency in DeltaKPQ Scn5a mice. J Cardiovasc Electrophysiol. 2006; 16(12):1329-40. DOI: 10.1111/j.1540-8167.2005.00200.x. View